Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma
Clinical trial NCT05036733 · COMPLETED
Trial details
- NCT number
- NCT05036733
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2023-06-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.